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Abstract
Background: Stress-induced cardiomyopathy (SIC) is an acute cardiac condition with akinesia in the left 
ventricle (LV) that can be severe. A stress-trigger, physical or emotional, is usually identified preceding onset of 
symptoms and catecholamine overstimulation is involved in the pathogenesis of SIC. The akinesia seen in SIC 
is reversible and the short term prognosis is therefore considered to be very good. However, recent data suggest 
that the long term prognosis is equivalent to patients suffering from myocardial infarction. Physical triggers 
and critical illness are the major triggers of SIC and especially patients with subarachnoid hemorrhage (SAH) 
frequently develop SIC. Patients with SIC after SAH have an increased risk of secondary cerebral infarction and 
have a worse short-term prognosis.
Aim: The aim was to evaluate if the biomarkers of myocardial injury (hsTNT) and cardiac dysfunction (NT-
proBNP) could be used for identification of patients with SIC after SAH and if patients with increased levels 
of hsTnT and NTproBNP had an increased risk of poor long-term prognosis (Paper I, II). In an experimental 
animal model of SIC, the aim was to evaluate cardioprotective properties of different anesthetics (Paper III, IV).
Methods: The first study (Paper I) was retrospective. Data was collected from all patients admitted to the 
NICU, Sahlgrenska University Hospital, during almost five years. Patients with an echocardiography performed 
and the biomarkers hsTnT or NTproBNP were obtained were included in the analysis. The second study (Paper 
II) was prospective. All consecutive patients admitted to the NICU, Sahlgrenska University Hospital, during two 
years were enrolled in the study. hsTnT and NTproBNP were taken on admission and the three following days 
and clinical data were obtained. Follow-up was performed one year after onset of symptoms. In Paper III and 
IV, SIC was induced with an intraperitoneal bolus of isoprenaline in Sprague Dawley rats. Different anesthetics 
were applied prior to induction of SIC. Vital parameters were measured and small animal echocardiography was 
performed. A proteomic analysis was performed for assessment of cardioprotective pathways.
Results: Patients with SIC after SAH could be identified with the cardiac biomarkers hsTnT and NTproBNP 
(Paper I). Increased levels of hsTnT were independently associated with a higher risk of poor long-term outcome 
when adjusted for age, neurological status on admission and cerebral infarction. Increased levels of hsTnT and 
NTproBNP was associated with a higher risk of delayed cerebral infarction (Paper II). In the experimental stu-
dies, isoflurane had a cardioprotective dose-response effect while propofol and ketamine were not cardioprotecti-
ve. The cardioprotective mechanism was not mediated through anesthesia per se, by reducing myocardial oxygen 
demand or by activating the mKatp-channels described in anesthetic preconditioning. In a proteomic analysis, 
we found that isoflurane attenuated virtually all the pathogenic pathways induced in SIC. Isoflurane seem to act 
by competitive inhibition the intracellular beta-receptor signalling pathway.
Conclusion: Patients with increased levels of hsTnT or NTproBNP have a higher risk of delayed cerebral infar-
ction and poor long-term prognosis. These patients should be examined with echocardiography for detection of 
SIC and cardiac output should be monitored to optimize hemodynamics, ensuring cerebral perfusion. Although 
many aspects are to be considered, isoflurane sedation might be beneficial in patients suffering from SAH.
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